Following a series of positive results from multiple vaccines, the conversation on Capitol Hill has shifted to the distribution and logistics of the COVID-19 vaccines. On December 10th, a group of freight industry executives, including Richard Smith, Regional President of the Americas and Executive Vice President at Fedex Express, and Wesley Wheeler, President of Global […]
Read More
With the impending release of Covid-19 vaccinations, there is much debate among the aviation industry and what requirements should be mandated when it comes to international travel. Airports Council International (ACI), a non-profit organization that represents the worlds airports, has joined many airlines in calling for a choice between testing or vaccination, fearing a blanket […]
Read More
This year has proven to be anything but normal, especially within the oil Industry. COVID-19 has certainly dampened oil demand throughout the world since March, but light is showing at the end of the tunnel. In just the past week we have had two highly effective vaccine candidates prove that our brilliant scientists may get […]
Read More
As many are aware, Pfizer announced on Monday that its COVID-19 vaccine candidate was 90% effective in trials on people who don’t have coronavirus. The test was conducted on 43,538 people and had no safety concerns. This brings up the biggest question of all, when the vaccine will be approved and available.
Read More
News of the Pfizer vaccine is spreading like wildfire around the world today. Covid-19 has killed more than 1.2 million people the world over. Today, Pfizer announced a vaccine that has a 90% effective rate with no serious safety concerns. If these numbers are to hold true, Pfizer’s new vaccine would hold up to the […]
Read More
Earlier this month both China and Russia reported that they have developed a Covid-19 vaccine that has been clouded by doubt throughout the world since Phase III testing had not been performed. The vaccines have been developed by CanSino Biologic from China and the Gamaleya Institute in Moscow and are a modification of adenovirus type […]
Read More
With the global COVID-19 case count reaching 20 million, Russia has approved a vaccine for the disease. There is, however, suspicion around the approval since the trials have yet to conclude the Phase 3 testing. To solidify the vaccine approval, Russian President Vladimir Putin, stated the vaccine is working “effectively enough”- far too vague for […]
Read More
To combat COVID-19, Moderna launched a Phase 1 study consisting of 45 participants in an effort to create a vaccine on an expedited timeline. March 16th was the start of the Phase 1 testing. The initial group of 45 people were divided into groups of 15 individuals. Each grouping received 2 doses of treatment, but […]
Read More
